The new drugs advent: clinical or economic outcomes?
De Maio
E
E
Clinical Trials Unit, National Cancer Institute of Naples, Naples, Italy.
Perrone
F
F
Bisagni
G
G
Boni
C
C
D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000191:economics / Q000401:mortality; D003362:Cost-Benefit Analysis; D017850:Economics, Pharmaceutical; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000191:economics / Q000401:mortality; D008495:Medical Oncology; D016019:Survival Analysis
D000970:Antineoplastic Agents